Delivery Order SPE2DB20D1004-SPE2DB24FF8A5

Award Date 4/11/24
Potential Completion Date 4/12/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $1,022.88, is for the delivery of 1,000 units of the prescription drug Montelukast Sodium 10 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which is valued at up to $999,999,999.00 and runs through December 31, 2025. This IDC...
This federal contract award, valued at $1,638.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the medication Montelukast Sodium 10 mg Tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of January 17, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
This federal contract award, valued at $1,003.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566698224 units of Montelukast Sodium 10 mg tablets, a medication used to treat conditions such as asthma and allergies. The contract has an ultimate completion date of December 13, 2024 and is structured as a Firm Fixed Price Delivery Order. This award is...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,557,734,379 units of Montelukast Sodium 10 mg tablets. The award has a ceiling value of $4,756.49 and was issued on July 7, 2022, with a completion date of July 8, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,240.64 fixed-price delivery order is for Montelukast Sodium 10 mg tablets, a medication used to treat asthma and allergies. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which enables efficient government procurement of a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,593.98, is for the delivery of montelukast sodium 10 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This contract award, valued at $1,039.28, is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of Montelukast Sodium 10 mg tablets in a quantity of 1,000s. The award has a firm-fixed price pricing type and an ultimate completion date of August 20, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $1,362.49, is for the delivery of Montelukast Sodium 4 mg Granules, a generic pharmaceutical product used for asthma and allergy treatment. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at...
This federal contract award, valued at $1,163.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Montelukast Sodium 4 mg granules, a medication used to treat asthma and other respiratory conditions. The contract has an ultimate completion date of January 14, 2025 and is a firm fixed-price delivery order with no set-aside designation, indicating open...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 1,000 units of the pharmaceutical product Montelukast Sodium 10 mg Tablets. The $1,425.54 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, with a completion date of November 9, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FF8A5
    Delivery Order

This federal contract award, with the ID SPE2DB20D1004|SPE2DB24FF8A5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of 1,000 units of Montelukast Sodium 10mg tablets, a pharmaceutical product, with a ceiling value of $1,054.65.

The contract is structured as a firm fixed price delivery order and does not have a set-aside designation. It is associated with a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued up to $999,999,999.00 with a period of performance through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense worldwide.

Generated 7/11/24, 9:05 AM